X @Bloomberg
Bloomberg·2025-07-24 06:38
Roche is weighing direct-to-patient drug sales in the US, bypassing the middleman for its pricey medicines for multiple sclerosis, eye disease and cancer https://t.co/pqP9ufmHaR ...
Roche is weighing direct-to-patient drug sales in the US, bypassing the middleman for its pricey medicines for multiple sclerosis, eye disease and cancer https://t.co/pqP9ufmHaR ...